NicOx

Industry · 15 registered clinical trials.

Status	Trial	Phase	Started
Withdrawn	Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240) Adenoviral Conjunctivitis	Phase 2	2017-01-01
Completed	ADenoVirus Initiative Study in Epidemiology in UK Viral Conjunctivitis	—	2015-02-01
Completed	ADenoVirus Initiative Study in Epidemiology in Italy Viral Conjunctivitis	—	2014-11-01
Completed	ADenoVirus Initiative Study in Epidemiology in Spain Viral Conjunctivitis	—	2014-07-01
Completed	ADenoVirus Initiative Study in Epidemiology in Germany Viral Conjunctivitis	—	2014-04-01
Completed	ADenoVirus Initiative Study in Epidemiology in France Viral Conjunctivitis	—	2013-06-01
Completed	Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male Pharmacokinetics	Phase 1	2010-01-01
Completed	Effect of Repeated Dosing of Naproxcinod on Renal Hemodynamic and on Sodium Balance in Healthy Volunteers Befo Renal Hemodynamics	Phase 1	2009-01-01
Completed	A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function Renal Failure	Phase 1	2008-05-01
Completed	To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Osteoarthritis, Hypertension	Phase 1	2008-03-01
Completed	A Study to Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Pat Osteoarthritis, Hypertension	Phase 1	2008-03-01
Completed	A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Liver Disease	Phase 1	2008-01-01
Completed	Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip Osteoarthritis, Osteoarthritis, Hip	Phase 3	2007-06-01
Completed	Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee Osteoarthritis	Phase 3	2007-04-01
Completed	Analgesic Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee Osteoarthritis	Phase 3	2005-12-01